Visualitza per autor "Alvarez-Larran, Alberto"
Ara mostrant els elements 1-4 d 4
-
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
Barbui, Tiziano; De Stefano, Valerio; Alvarez-Larran, Alberto; Iurlo, Alessandra; Masciulli, Arianna; Carobbio, Alessandra; Fox, Maria Laura (Springer Nature, 2021-02-04) -
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
Alvarez-Larran, Alberto; Cuevas, Beatriz; Velez Tenza, Patricia; Noya, Soledad; Caballero-Navarro, Gonzalo; Ferrer-Marin, Francisca; Fox, Maria Laura (Wolters Kluwer Health, 2023-08) -
Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis
García Fortes, María; Alvarez-Larran, Alberto; Raya, José M.; Angona, Anna; Estrada, Natalia; Fox, Maria Laura; Hernandez-Boluda, Juan Carlos (MDPI, 2022-05) -
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Alvarez-Larran, Alberto; Garrote, Marta; Bellosillo, Beatriu; Pérez-Encinas, Manuel; Mata Vázquez, María Isabel; Fox, Maria Laura; Ferrer-Marin, Francisca (Wiley, 2022-07-01)